NVD3

3x exposure
to NVIDIA stock

View NVD3
  • No need of a margin or CFD account.
  • Physically-backed products.
  • Traded on exchange like other stocks.
  • 2,006,857 shares held of NVDA
  • Trade
    in USD, GBP & EUR
  • -5.09% by Performance YTD*
Past performance is not indicative of future results.
*Source: Leverage Shares, based on NAV performance as of 27 11 2025.

Why 3x Long NVIDIA?

Potential Ways
to Gain Magnified Exposure		 Futures Option Spread Betting /
CFDs		 Warrants /
Turbos		 Leveraged
Certificates		 Leverage Shares
ETPs¹
Constant Leverage Factor
Losses Capped at Invested Amount
Low Minimum Trade Size
No Maintenance Margin Required
Physically-Backed
Dedicated Market Maker
No Bank Credit Risk²
Traded on a Regulated Exchange

¹ Leverage Shares are margin-based ETPs that provide 5x, 3x, 2x, -1x -2x, -3x & -5x exposure to individual stocks & ETFs.

² Although credit risk is reduced, other risks still apply.

All leveraged products carry significant risk of loss and may not be suitable for all investors.

Listings & Tickers

Country Exchange Base
Currency		 Trading
Currency		 Exchange
Code		 ISIN SEDOL BBG Ticker RIC WKN Listing Date
UK London Stock Exchange USD USD NVD3 XS2820604770 BSQMNK6 NVD3 LN NVD3.L N/A 04 Jun 2020
UK London Stock Exchange USD GBP 3NVD XS2820604770 BSQMNN9 3NVD LN 3NVD.L N/A 04 Jun 2020
UK London Stock Exchange USD EUR 3NVE XS2820604770 BSQMNM8 3NVE LN 3NVE.L N/A 04 Jun 2020
NL Euronext Amsterdam USD EUR 3NVD XS2820604770 BSQMNP1 3NVD NA 3NVD.AS N/A 12 Jan 2021
IT Borsa Italiana USD EUR 3NVD XS2820604770 BSQMNQ2 3NVD IM 3NVD.MI N/A 16 Feb 2022
DE Deutsche Börse Xetra USD EUR NVI3 XS2820604770 BSQMNR3 NVI3 GY NVI3.DE A4AGVL 14 Apr 2022

ETP Documents

Fact Sheet
Final Terms CBI Final Terms FCA
2025-11 UK DE ES FR IT NL PL SV
2025-10 UK DE ES FR IT NL PL SV
2025-09 UK DE ES FR IT NL PL SV
2025-08 UK DE ES FR IT NL PL SV
2025-07 UK DE ES FR IT NL PL SV
2025-06 UK DE ES FR IT NL PL
2025-05 UK DE ES FR IT NL PL
2025-04 UK DE ES FR IT NL PL
2025-03 UK DE ES FR IT NL PL
2025-02 UK DE ES FR IT NL PL
2025-01 UK DE ES FR IT NL PL
2024-12 UK DE ES FR IT NL PL
2024-11 UK DE ES FR IT NL PL
2024-10 UK DE ES FR IT NL PL
2024-09 UK DE ES FR IT NL PL
2024-08 UK DE ES FR IT NL PL
2024-07 UK DE ES FR IT NL PL
2024-06 UK DE ES FR IT NL PL
2024-05 UK DE ES FR IT NL PL
2024-04 UK DE ES FR IT NL PL
2024-03 UK DE ES FR IT NL PL
2024-02 UK DE ES FR IT NL PL
2024-01 UK DE ES FR IT NL PL
2023-12 UK DE ES FR IT NL PL
2023-11 UK DE ES FR IT NL PL
2023-09 UK DE ES FR IT NL PL
2023-08 UK DE ES FR IT NL PL
2023-07 UK DE ES FR IT NL PL
2023-06 UK DE ES FR IT NL PL
2023-05 UK DE ES FR IT NL PL
2023-04 UK DE ES FR IT NL PL
2023-03 UK DE ES FR IT NL PL
2023-02 UK DE ES FR IT NL PL
2023-01 UK DE ES FR IT NL PL
2022-12 UK DE ES FR IT NL PL
UK Fund Reporting
Reportable Income
EMT
Prospectus (FCA) 23 June 2025 Prospectus (CBI) 23 June 2025 Prospectus (CBI) 17 July 2024 Prospectus (FCA) 17 July 2024 Prospectus (CBI) 15 March 2024 Prospectus (FCA) 15 March 2024 Prospectus (FCA) 18 October 2023 Prospectus (CBI) 18 October 2023 Prospectus (FCA) 4 May 2023 Prospectus (CBI) 4 May 2023 Supplement 1 June 2022 Prospectus 16 May 2022 Prospectus 7 December 2021 Supplement 8 October 2021 Supplement 17 September 2021 Supplement 6 May 2021 Supplement 4 March 2021 Prospectus 18 December 2020 Prospectus 6 November 2020 Prospectus 5 February 2020
Half Financial Year Ended 31.12.2024 Financial Year Ended 30 June 2024 Half Financial Year Ended 31.12.2023 Financial Year Ended 30.06.2023 Half Financial Year Ended 31.12.22 Financial Year Ended 30.06.22 Half Financial Year Ended 31.12.21 Financial Year Ended 30.06.21 Half financial year ended 31.12.20 Financial Year Ended 30.06.20 Half Financial Year Ended 31.12.19 For the Year Ended 30.06.19 From 01.07.18 to 31.12.18 From 27.01.17 to 30.06.18

Notices

Latest Notice
31.10.2025 Notice of Publication of Audited Financial Statements 06.08.2025 Updated to IB Margin Account Agreement 07.05.2025 Notice Appointment of Additional Authorised Participant 27.01.2025 Notice of Intraday Rebalance 13.01.25 Notice to ETP Securityholders 02.10.2024 Notice of Amended & Restated Margin Account Agreement 26.07.2024 Notice of Appointment of Pershing as Additional Margin Load Provider 17.07.2024 Notice of Deed of Amendment and Restatement 10.07.2024 Notice of Increase in Margin Rate 10.05.2024 Upcoming Corporate Actions (AAP2, MSF2, NVD2, NVD3) 08.05.2024 Results of Adjourned Meeting 23.04.2024 Notice of Meeting 26.03.2024 Meeting Notice 27.03.2024 Notice of Clerical Errors 01.11.2023 Notice of Late Filing of Audited Financial Report 26.10.2023 Notice of Amended Final Terms 18.10.2023 Notice to ETP Securityholders 19.09.2023 Notice of Migration to IB LLC 04.05.2023 Notice of Amended and Restated Conditions 13.12.2022 Notice of Result of Adjourned Meeting 09.12.2022 Notice of Extension of Deadline 29.11.22 Notice of Delisting from Euronext Paris 12.10.22 Intraday Rebalance 12.09.2022 Notice of Cross Listing (Deutsche Borse Xetra) 19.08.22 Notice of Mandatory Redemption 16.08.22 Notice of Amended and Restated Master Trust Deed 08.08.22 Mandatory Redemption 20.07.22 Intraday Rebalance 18.07.22 Intraday Rebalance 15.07.22 Intraday Rebalance 01.07.22 Intraday Rebalance 21.06.22 Intraday Rebalance 14.06.2022 Notice of Delisting 14.06.22 Notice of Delisting 13.06.22 Intraday Rebalance 24.05.22 Intraday Rebalance 13.05.22 Intraday Rebalance 12.05.22 Intraday Rebalance 12.05.2022 Notice of Waiver of Arranger Fee 09.05.22 Intraday Rebalance 09.05.22 Intraday Rebalance 05.05.22 Intraday Rebalance 05.05.22 Notice of Issuer Call Redemption 05.05.22 Intraday Rebalance 27.04.2022 Notice of Issuer Call Redemption 20.04.22 Intraday Rebalance 20.04.22 Intraday Rebalance 29.03.2022 Notice of Waiver of Arranger Fee 23.03.22 Notice of Series Name Change 16.03.22 Intraday Rebalance 16.03.22 Intraday Rebalance 14.03.22 Intraday Rebalance 10.03.22 Intraday Rebalance 07.03.22 Notice of Delisting from CBOE Europe Limited. 18.02.22 Intraday Rebalance 16.02.22 Intraday Rebalance 03.02.22 Intraday Rebalance 03.02.22 Intraday Rebalance 02.02.22 Intraday Rebalance 31.01.22 Intraday Rebalance 21.01.22 Intraday Rebalance 21.01.22 Intraday Rebalance 31.12.21 Intraday Rebalance 07.12.21 Notice of Amended and Restated Terms and Conditions Notice of Intraday Rebalance and Issuer Call Redemption Notice to ETP Securityholders 23.11.21 Notice of Intraday Rebalance Notice of Change of Portfolio Administrator 16.11.21 Notice to ETP Securityholders 09.11.2021 Notice to ETP Securityholders 08.10.21 Notice of Arranger Fee Increase 27.09.21 Notice of Change of Portfolio Administrator 17.09.2021 Notice of Fee Increase 17.09.2021 Notice of Fee Decrease 31.08.21 Intraday Rebalance 12.04.21 Notice of Cross Listing 26.01.21 Notice of Cross Listing (Euronext Paris) 12.01.21 Notice of Cross Listing (Euronext Amsterdam) 23.12.20 Notice of Termination of Service Providers 18.12.20 Notice of Confirmation of Migration to ICSD 08.12.20 Notice of Migration to ICSD 27.11.20 Notice of Change of Issuing and Paying Agent 27.10.20 Notice of Change of Service Providers

Common Investor Questions

This is a marketing communication. Prospective investors should refer to the Exchange Traded Product ("ETP") Prospectus and Key Investor Information Document (KIID) before making any investment decisions.

No Legal or Investment Advice
The information on this website does not constitute legal, financial, or investment advice. It should not be considered an offer to sell or a solicitation to buy any security, including shares of any ETP promoted here, or other financial instruments, products, or services offered by Leverage Shares or its distributors ("Leverage Shares").

Investment Advice & Client Services
Leverage Shares constructs and issues ETPs but does not provide services to private investors, nor does it accept client funds directly. Leverage Shares’ services are exclusively available to professional clients, as defined in this website’s Terms and Conditions. Private investors should consult their personal advisor, broker, or bank for investment or trading inquiries. For technical questions regarding our ETPs, please contact us directly.

Investment Decisions
Any investment in promoted ETPs should be based on the official sales Prospectus, the relevant Supplement, and the KIID, which outline the applicable terms and conditions.

Investment Risks
Investments in ETPs are subject to risk, including potential loss of principal. The value of investments may fluctuate, and investors may not recover the amount originally invested. Past performance is not indicative of future results and should not be the sole factor considered in selecting a product. Investors should carefully consider their investment objectives, risks, charges, and expenses before investing.

Documentation & Availability
The Prospectus, KIID, and other relevant documentation are available free of charge on this website, and upon request via email. Please note that except for KIIDs, documents are generally available in English and selected other languages.

Regulatory Information
Investium Limited, has been appointed as distributor of Leverage Shares products in Europe.Investium Limited, with registered address at 6 Nikou Georgiou Street, Office 302, 1095 Nicosia Cyprus, is a financial services provider regulated by the Cyprus Securities and Exchange Commission (CySEC).

Not Insured — No Bank Guarantee — May Lose Value

© Leverage Shares2025